Do you want to read an article? Please log in or register.
Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn's Disease: the USBIOS IG-IBD Study
Inflammatory Bowel Disease
Indications
Related content
Inflammatory Bowel Disease
Clinical outcomes following switch from risankizumab to guselkumab in Crohn's disease: a real-world case series
J Crohns Colitis
Farkouh A, Nathoo-Khedri N, Dufresne A, Danaie H, Battat R
doi: 10.1093/ecco-jcc/jjag089
Inflammatory Bowel Disease
Clinical Outcome After Entero-Enteric Anastomosis for Crohn's Disease: A Case-Control Study
J Crohns Colitis
Neri B, Schiavone SC, Mancone R, Fiorillo M, Fonsi A, Calabrese E, Perugini L, Piccione G, Di Matteo FM, Marafini I, Lolli E, Sica GS, Monteleone G, Biancone L
doi: 10.1093/ecco-jcc/jjaf163
Inflammatory Bowel Disease
Establishing a Multiple Outcome Set for Crohn's Disease in Real-World Evidence Studies: Results from a Delphi e-Survey
J Crohns Colitis
Moreira PL, Dignass A, Estevinho MM, Santiago M, Reinisch W, Sands BE, D'Haens G, Mantzaris GJ, Danese S, Peyrin-Biroulet L, Dotan I, Jairath V, Magro F, International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)
doi: 10.1093/ecco-jcc/jjaf178
Inflammatory Bowel Disease
Long-term disease course of Crohn's disease in a prospective European population-based inception cohort - an Epi-IBD cohort study
Clin Gastroenterol Hepatol
Wewer MD, Lophaven S, Lakatos PL, Gonczi L, Salupere R, Linda Kievit HA, Nielsen KR, Midjord J, Domislovic V, Krznarić Ž, Pedersen N, Kjeldsen J, Halfvarson J, Sebastian S, Goldis A, Arebi N, Oksanen P, Neumann A, Andersen V, Katsanos KH, Koukoudis A, Turcan S, Ellul P, Kupcinskas J, Kiudelis G, Fumery M, Kaimakliotis IP, D'Inca R, Lombardini S, Hernandez V, Fernandez A, Langholz E, Munkholm P, Burisch J, Epi-IBD-group.
doi: 10.1016/j.cgh.2025.10.022
Inflammatory Bowel Disease
Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg
J Crohns Colitis
De Greef E, Turner D, Kierkuś J, Korczowski B, Meglicka M, Cohen SA, Hyams JS, Griffiths AM, Rosh JR, Strauss R, Van Limbergen E, Adedokun OJ, Kim L, Volger S, UNITI Jr study Group
doi: 10.1093/ecco-jcc/jjag011
Inflammatory Bowel Disease
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry
United European Gastroenterol J
Mañosa M, Calafat M, Ricart E, Nos P, Iglesias E, Riestra S, Mesonero F, Calvo M, Guardiola J, Hernández V, Rivero M, Carpio D, Mínguez M, Alba C, Martín-Arranz MD, Vela M, Gomollón F, García-López S, Casbas AG, Calvet X, González-Muñoza C, Barrio J, Gisbert JP, Sicilia B, Pérez-Calle JL, Bujanda L, Esteve M, Ramos L, Varela P, Sierra M, Merino O, Bermejo F, Acosta MB, Perez AR, Márquez-Mosquera L, García-Bosch O, Rodríguez-Lago I, Lorente Poyatos RH, García Sepulcre MF, Maroto N, Vega P, Monfort D, San Martín LZ, Busquets D, Martinez-Montiel P, Riera J, Alcain G, Llaó J, Marin N, Marin-Jimenez I, Sesé E, Van Domselaar M, Huguet JM, Ginard D, Bas-Cutrina F, Ber Y, Roncero O, Lucendo AJ, López-García A, Menacho M, Almela P, Ponferrada Á, Coronel AF, Maestro S, de Jesús Martínez-Pérez T, Vilafranca CM, Argüelles F, Legido J, Gilabert P, Charro M, Trapero AM, Fernández H, Frago S, Villalba LH, Muñoz E, Domènech E, ENEIDA registry of GETECCU
doi: 10.1002/ueg2.70150
Inflammatory Bowel Disease
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE Study
Adv Ther
Privitera G, Palumbo F, Macaluso FS, Laterza L, Pardi V, Viola A, Noviello D, Barberio B, Ricci C, Balestrieri P, Cappello M, Maconi G, Sablich R, Variola A, Bennato R, Pastorelli L, Grossi L, Ribaldone DG, Buda A, Bossa F, Di Sario A, Viscido A, Neri B, Mocci G, Pagnini C, Principi MB, Coletta M, Petruzzellis C, Mazzuoli S, Festa S, Mirarnda A, Bezzio C, Fanigliulo L, Rocco G, Pont ED, Spagnuolo R, Savarino EV, Caprioli FA, Fries W, Ceccarelli L, Scaldaferri F, Orlando A, Testa A, Pugliese D, Armuzzi A
doi: 10.1007/s12325-026-03675-4
Inflammatory Bowel Disease
Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B SEQUENCE Study
Am J Gastroenterol
Loftus EV Jr, Joshi N, Sands BE, Jairath V, Blumenstein I, Shukla N, Kligys K, Anschutz T, Griffith J, Zambrano J, Louis E
doi: 10.14309/ajg.0000000000004044
Inflammatory Bowel Disease
Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial
J Crohns Colitis
Bhandari M, Sharip MT, Noor NM, Khwaja S, Paverd H, De Paepe KN, Godfrey E, Hickman K, Patel KV, Subramanian S, Raine T, Lee JC, Kennedy NA, Upponi S, Parkes M, PROFILE Study Group
doi: 10.1093/ecco-jcc/jjag056